Filtered By:
Procedure: Liver Transplant
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 13525 results found since Jan 2013.
COVID-19 in transplant recipients: Multicentric report of Mexican experience
CONCLUSIONS: Transplant recipients show a higher fatality rate and complications from SARS-CoV-2 infection; more studies are needed to identify prognostic factors and effective anti-SARS-CoV-2 therapies.PMID:37669570 | DOI:10.24875/ACM.21000113
Source: Archivos de Cardiologia de Mexico - September 5, 2023 Category: Cardiology Authors: M ónica Sánchez-Cárdenas Enzo V ásquez-Jiménez Ricardo I Vel ázquez-Silva Mario Vilatob á-Chapa Benjam ín Gómez-Navarro Lucio O S ánchez-Macías Jos é M Rodríguez-Chagolla Ignacio Garc ía-Juárez Severo M Abraham-Mancilla Luis E Morales-Buenr Source Type: research
Circulating copeptin level and the clinical prognosis of patients with chronic liver disease
CONCLUSION: Patients with CLD who have high serum copeptin concentrations may be associated with a poor clinical prognosis.PMID:37664154 | PMC:PMC10473920 | DOI:10.3748/wjg.v29.i31.4797
Source: World Journal of Gastroenterology - September 4, 2023 Category: Gastroenterology Authors: Hao-Qian Tan Ming Zhao Zan Huang Yang Liu Han Li Long-Hui Ma Jun-Ying Liu Source Type: research
Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases
Stem Cell Res Ther. 2023 Sep 4;14(1):235. doi: 10.1186/s13287-023-03476-4.ABSTRACTAlthough mesenchymal stem cell (MSC) transplantation provides an alternative strategy for end-stage liver disease (ESLD), further widespread application of MSC therapy is limited owing to low cell engraftment efficiency. Improving cell engraftment efficiency plays a critical role in enhancing MSC therapy for liver diseases. In this review, we summarize the current status and challenges of MSC transplantation for ESLD. We also outline the complicated cell-homing process and highlight how low cell engraftment efficiency is closely related to hu...
Source: Cell Research - September 4, 2023 Category: Cytology Authors: Shaoxiong Yu Saihua Yu Haiyan Liu Naishun Liao Xiaolong Liu Source Type: research
Circulating copeptin level and the clinical prognosis of patients with chronic liver disease
CONCLUSION: Patients with CLD who have high serum copeptin concentrations may be associated with a poor clinical prognosis.PMID:37664154 | PMC:PMC10473920 | DOI:10.3748/wjg.v29.i31.4797
Source: World Journal of Gastroenterology : WJG - September 4, 2023 Category: Gastroenterology Authors: Hao-Qian Tan Ming Zhao Zan Huang Yang Liu Han Li Long-Hui Ma Jun-Ying Liu Source Type: research
Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients
Aging (Albany NY). 2023 Sep 2;15. doi: 10.18632/aging.204982. Online ahead of print.ABSTRACTLiver transplant (LT) candidates have become older and frailer, with growing Non-alcoholic steatohepatitis (NASH) and comorbid disease burden in recent years, predisposing them for poor waitlist outcomes. We aimed to evaluate the impact of access to living donor liver transplantation (LDLT) in waitlisted patients at highest risk of dropout. We reviewed all adult patients with decompensated cirrhosis listed for LT from November 2012 to December 2018. Patients with a potential living donor (pLD) available were identified. Survival ana...
Source: Aging - September 4, 2023 Category: Biomedical Science Authors: Fakhar Ali Qazi Arisar Shiyi Chen Catherine Chen Noorulsaba Shaikh Ravikiran Sindhuvalada Karnam Wei Xu Sumeet K Asrani Zita Galvin Gideon Hirschfield Keyur Patel Cynthia Tsien Nazia Selzner Mark Cattral Leslie Lilly Mamatha Bhat Source Type: research
Circulating copeptin level and the clinical prognosis of patients with chronic liver disease
CONCLUSION: Patients with CLD who have high serum copeptin concentrations may be associated with a poor clinical prognosis.PMID:37664154 | PMC:PMC10473920 | DOI:10.3748/wjg.v29.i31.4797
Source: World Journal of Gastroenterology - September 4, 2023 Category: Gastroenterology Authors: Hao-Qian Tan Ming Zhao Zan Huang Yang Liu Han Li Long-Hui Ma Jun-Ying Liu Source Type: research
Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients
Aging (Albany NY). 2023 Sep 2;15. doi: 10.18632/aging.204982. Online ahead of print.ABSTRACTLiver transplant (LT) candidates have become older and frailer, with growing Non-alcoholic steatohepatitis (NASH) and comorbid disease burden in recent years, predisposing them for poor waitlist outcomes. We aimed to evaluate the impact of access to living donor liver transplantation (LDLT) in waitlisted patients at highest risk of dropout. We reviewed all adult patients with decompensated cirrhosis listed for LT from November 2012 to December 2018. Patients with a potential living donor (pLD) available were identified. Survival ana...
Source: Aging - September 4, 2023 Category: Biomedical Science Authors: Fakhar Ali Qazi Arisar Shiyi Chen Catherine Chen Noorulsaba Shaikh Ravikiran Sindhuvalada Karnam Wei Xu Sumeet K Asrani Zita Galvin Gideon Hirschfield Keyur Patel Cynthia Tsien Nazia Selzner Mark Cattral Leslie Lilly Mamatha Bhat Source Type: research
Circulating copeptin level and the clinical prognosis of patients with chronic liver disease
CONCLUSION: Patients with CLD who have high serum copeptin concentrations may be associated with a poor clinical prognosis.PMID:37664154 | PMC:PMC10473920 | DOI:10.3748/wjg.v29.i31.4797
Source: World Journal of Gastroenterology : WJG - September 4, 2023 Category: Gastroenterology Authors: Hao-Qian Tan Ming Zhao Zan Huang Yang Liu Han Li Long-Hui Ma Jun-Ying Liu Source Type: research
